Platelet reactivity assay and CYP2B6 mutations predict clinically significant ticagrelor-related bleeding in Asians
Oral poster presented at Singapore Health and Biomedical Conference
Saved in:
Main Authors: | Leong WQ, Kim JH, Aw WX, Tan D |
---|---|
Other Authors: | PHARMACY |
Format: | Article |
Published: |
2020
|
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/176994 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Real-World Incidence rates of Bleeding in Asian Patients on Prasugrel and Ticagrelor
by: DSY Tan, et al.
Published: (2020) -
A review of the effects of ticagrelor on adenosine concentration and its clinical significance
by: Akkaif, MA, et al.
Published: (2021) -
Repurposing a platelet aggregation inhibitor ticagrelor as an antimicrobial against Clostridioides difficile
by: Matthew Phanchana, et al.
Published: (2020) -
Switching from Ticagrelor to Clopidogrel in Asian Patients with ST-Elevated Myocardial Infarction – A Time Dependent Analysis Study
by: Koh L, et al.
Published: (2020) -
Early predictors of clinically significant bleeding in adults with dengue infection
by: Supat Chamnanchanunt, et al.
Published: (2018)